Wound Management Technologies, Inc., through its subsidiary, Wound Care Innovations, LLC, distributes collagen-based wound care products in the United States. The company holds worldwide license to certain technologies and processes related to a collagen-based wound care product formulation under the brand name CellerateRx. It markets CellerateRx for pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns, and superficial wounds.
